Skip to main content
. 2021 Nov 20;100(2):215–243. doi: 10.1007/s00109-021-02163-2

Fig. 2.

Fig. 2

AHR antagonists and CYP1A1 inhibitors used in vivo. Chemical structures of AHR antagonists (A) and non-selective CYP1A1 inhibitors (B)